INTRODUCTION
A ngiogenesis, formation of new blood vessels from existing vessels, is precisely controlled by angiogenic and angiostatic cytokines [1] . It is involved in various pathological processes, including inflammation, wound healing, and tumor growth [2] [3] [4] . When pathological angiogenesis occurs in the eye, as in neovascular age-related macular degeneration (nAMD) or proliferative diabetic retinopathy (PDR), vision may be heavily impaired and may progress to blindness [5] [6] . In an aging population with rising living standards, the morbidity rate of nAMD and PDR is increasing, leading to decreased quality of life and increasing health care burdens [7] . Therefore, ophthalmologists are paying increasing attention to prevention of vision loss by inhibiting ocular neovascularization. Many studies suggest that macrophages migrate to lesion sites and modulate angiogenesis via the action of a number of cytokines [8] . The recruited macrophages or resident macrophages differentiate into subtypes depending on the specific microenvironment [9] . The first step is migration to lesion sites after binding to chemokines [10] . Chemokines are members of a superfamily of small signaling molecules that regulate migration of target cells [11] . Monocyte chemoattractant protein 1 (MCP-1/CCL2), a member of the C-C motifchemokine subfamily, exhibits chemotactic potential for monocytes/macrophages via binding to its cognate receptors CCR2 or CCR4. In addition, CX3C chemokine ligand 1 (CX3CL1/fractalkine), a member of C-X-C motif-chemokine subfamily, can also recruit mononuclear cells (including macrophages) to lesion sites by binding to CX3CR1 [12] [13] [14] [15] .
MCP-1 and fractalkine in angiogenesis
Several studies suggest that CCL2 and CX3CL1 are involved in development of pathological neovascularization, including monocytes/macrophages recruitment, and mediation of cytokine secretion by target cells [16] [17] . Vascular endothelial growth factor A (VEGF-A), one of the most potent proangiogenic factors, promotes vascular endothelium migration and proliferation [18] . Thrombospondin 1 (THBS-1)
and ADAMTS-1 (a disintegrin and metalloproteinase with a thrombospondin motif), are principal anti-angiogenic factors. These factors suppress neovascularization by counteracting VEGF-A, thereby inhibiting endothelial cell migration and survival [19] . In our study, we examined the effects of recombinant human CCL2 protein (rh-CCL2) and recombinant human CX3CL1 protein (rh-CX3CL1) on macrophages in vitro. into each polypropylene tube. The samples were divided into CD68+CCR2 and CD68+CX3CR1 groups. Group CD68+CCR2 was stained with PE-conjugated mouse antihuman CD68 antibody (1:100) and rabbit anti-human CCR2 antibody (1:100); Group CD68+CX3CR1 was stained with PE-conjugated mouse anti-human CD68 antibody (1:100) and rabbit anti-human CX3CR1 antibody (1:100). The samples were then incubated in the dark for 30min. Following PBS washing and two centrifugations, the samples were incubated with appropriate secondary antibodies in the dark for 30min. The samples stained with non-immunized mouse IgG mAb and rabbit IgG were used as isotype controls. All samples were detected using flow cytometry. The data was then analyzed using FlowJo version 10 software (USA).
MATERIALS AND METHODS Samples Preparation

Intervention on Macrophages with CCL2 or CX3CL1
Monocyte-derived macrophages were seeded on 6-well plates at a density of 5×10 5 cells/well. Cells were pre-cultured in RPMI-1640 supplemented with 10% FBS containing GM-CSF. Medium was replaced with serum-free medium for 6h followed by replacement with complete medium supplemented with 10% FBS. rh-CCL2 or rh-CX3XL1 in various concentrations was added to appropriate groups and the cells were incubated for 12h at 37℃ in a humidified incubator with 5% CO 2 . The cells were then pooled for subsequent assays.
Quantitative Reverse Transcription Polymerase Chain Reaction
The mRNAs of angiogenesis-related cytokines expressed by macrophages were examined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Total mRNA of the cells treated with rh-CCL2 or rh-CX3CL1 was extracted with the RNeasy mini Kit according to manufacturer's instructions. The resultant RNA preparations were further treated with ribonuclease-free deoxyribonuclease (DNase) I (Life Technologies, Gaithersburg, MD, USA) to remove genomic DNA. Next, cDNAs from the RNA preparations were generated by reverse transcription. VEGF-A, THBS-1 and ADAMTS-1 were amplified with SYBR Premix Ex Taq on a CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad Laboratories, USA). mRNA expression levels were measured according to the Ct value produced by each gene. Relative expression levels normalized to housekeeping gene β-actin were evaluated using the 2 -ΔΔCt method, where Ct represents the threshold cycle, and β-actin was used as a reference gene. Primers used are listed in Table 1 . Proliferation Assay In order to confirm whether the cytokines released by macrophages regulate the proliferation of HREC, we carried out a proliferation assay. Cultured macrophages were treated with rh-CCL2 or rh-CX3CL1 for 24h. Then the medium was replaced with fresh medium for another 24h. Supernatants were then collected. Totally 5×10 3 HREC in 100 μL DMEM were seeded in 96-well plates and divided into control, rh-CCL2 and rh-CX3CL1 groups. Each group was replicated in five wells. Six hours later, when the HREC were attached to the plate, the medium was removed and an equivalent volume of the collected supernatants from macrophages culture medium were added to appropriate groups. After 12 to 48h stimulation of HREC with the supernatant, the absorbance was measured at 6, 12, 24 and 48h. The inhibition rate (IR) for the proliferation of cells in different groups was compared to control groups. The data was analyzed using GraphPad Prism 6. Migration Assay To evaluate the effect of intervened macrophages on the migration of HREC, a modified Boyden chamber assay was performed as described previously [20] .
Briefly, 2.5×10 4 macrophages in 500 μL DMEM were seeded in the lower chambers and were treated with rh-CCL2 or rh-CX3CL1. After 24h incubation, the medium was replaced and fresh DMEM was added for another 24h. The 1×10 4 HREC in 100 μL DMEM were seeded in upper chambers. After coculture for 24h, migrated HREC were fixed prior to staining with 0.5% crystal violet solution. Non-invading cells were removed by a cotton swab. The infiltrated cells were counted under phase contrast microscopy.
Statistical Analysis
The data in this study were assessed using the Shapiro-Wilk test according to the normal distribution.
Variables were expressed as mean±SD. The equality of variances was assessed by Levene's test. Various expression levels in each group were determined by one-way ANOVA, and for multiple comparisons Dunnett's test was used for intergroup comparisons. P<0.05 were considered statistically significant. Statistical analyses were performed with GraphPad Prism 6.0 (GraphPad Software, Inc., USA). RESULTS Induction of Macrophages by GM-CSF The cells isolated from peripheral blood completely adhered to the plates 2h after plating. The shapes of these cells were ovoid, pyramidal, or fusiform. Primary cultured cells survived for approximately 2wk without stimulation by GM-CSF. Nevertheless, we detected numerous dead cells floating in the medium. The viability of cells was enhanced markedly after addition of GM-CSF. Cells grew stably with GM-CSF stimulation and the mortality was markedly reduced (Figure 1 ). Induced macrophages were passaged every 3d and the cells were used for assays within five passages.
CCR2 and CX3CR1 Expression on Macrophages
To examine the induction rate of macrophages from PBMC, cells were stained with CD68 (a macrophage marker) and were detected using flow cytometry. Cells treated with GM-CSF expressed CD68 (91%±4.4%), indicating that the cells were macrophages. To further verify whether CCR2 and CX3CR1 receptors for CCL2 and CX3CL1 were expressed on macrophages respectively, anti-CCR2 and anti-CX3CR1 antibodies were employed. Both CCR2 and CX3CR1 were co-expressed with CD68 on the membrane of cultured cells. CX3CR1 expression was higher than CCR2 expression on macrophages. The mean expression of CCR2 was 42%±1.9% while the mean expression of CX3CR1 was 71%±3.3% ( Figure 2 ). These results suggest that PBMC could be induced into macrophages by GM-CSF. Additionally, both the relative cognate receptors for CCL2 and CX3CL1 were expressed on macrophages. Expression of these receptors is crucial for macrophages to engage in further biological functions by binding to relevant chemokines.
MCP-1 and fractalkine in angiogenesis
Angiogenesis-related Cytokine Expression in Various
Macrophage Subtypes mRNA levels of VEGF-A were higher when stimulated with rh-CCL2, while mRNA levels of Figure 4 ). This data suggests that both CCL2 and CX3CL1 regulate the expression of cytokines by macrophages. However, the effects of CCL2 and CX3CL1 on macrophages are opposite, depending on their cellular cytokine profile.
Divergent Macrophages Populations Modulate the Migration of HREC
The migration of endothelium is an initial step for angiogenesis. We performed a migration assay to characterize macrophages stimulated by various cytokines. When cocultured with CX3CL1-treated macrophages, the infiltration number of HREC crossing through the upper chamber decreased. Positive-stained migrated cell numbers in the CX3CL1 group were 119±63 and 236±34 in control group (P<0.05). The number of migrated HREC increased (410±100) when incubated with CCL2-treated macrophages compared to control group (P<0.05; Figure 5 ). This suggests that different macrophages subtypes, induced by different chemokines, have the ability to mediate HREC behavior of migration by secreting different cytokines. DISCUSSION Chemokines and their cognate receptors are involved in a number of physiological and pathological processes via their chemotactic properties: embryonic development, immunity, wound healing, inflammation, tumor growth and angiogenesis [21] [22] [23] . In the process of neovascularization, CCL2 directly promotes vascular endothelial migration. CCL2 has the ability to induce macrophages to release angiogenic factors such as VEGF-A, IFN-γ and IL-6, resulting in enhanced angiogenesis [24] [25] [26] . At early stages of neovascularization, with stimulation by CCL2, macrophages secrete a variety of pro-angiogenic cytokines. In the case of ocular neovascularization, there is evidence that macrophages are involved in modulating vascular formation. Wallace et al [27] and Tsutsumi-Miyahara et al [28] reported that macrophages are [29] . It is well established that macrophages participate in various pathological processes, including myocardial ischemia, tumor angiogenesis, as well as ocular neovascularization [30] .
MCP-1 and fractalkine in angiogenesis
Macrophages are characterized by their heterogenic phenotypes. Particular micro-environments induce macrophages differentiation into distinctive subtypes. In addition to pro-angiogenic macrophages, there are anti-angiogenic macrophages that release angiostatic cytokines to suppress angiogenesis. Hence, when recruited by different types of chemokines such as CCL2, CCL5 and CX3CL1, macrophages release a series of angiogenic or angiostatic factors such as VEGF-A, THBS-1 and ADAMTS-1 to tip the balance of cytokine expression to either pro-angiogenesis or anti-angiogenesis [31] [32] . It would contribute our understanding of the mechanisms of pathological neovascularization if we knew more about the pro-angiogenic or anti-angiogenic functions of infiltrated polarized macrophages.
In our previous study, we showed that high CCR2 and low CX3CR1 expressing macrophages promoted corneal neovascularization by secreting VEGF and bFGF, while high CX3CR1 and low CCR2 expressing suppressed corneal neovascularization by secreting THBS-1 and ADAMTS-1. This suggested that CCL2/CCR2 and CX3CL1/CX3CR1 signaling are involved in corneal neovascularization, mediated by macrophages [33] . There is substantial evidence that the character of functions exhibited by macrophages depends on their microenvironment that polarizes macrophages into specific subtypes [9, [34] [35] . In present study, we explored the effects of CCL2 and CX3CL1 on macrophage secreting functions by stimulating them with the functional recombinant proteins of CCL2 and CX3CL1, respectively. We found that mRNA expression of VEGF-A was increased when stimulated with rh-CCL2. In contrast, expression of THBS-1 and ADAMTS-1 decreased. VEGF-A is a pivotal angiogenic factor characterized by its strong pro-angiogenic function while THBS-1 and ADAMTS-1 are angiostatic factors that suppress neovascularization. The effects of CCL2 upregulating VEGF-A expression and simultaneously downregulating expression of THBS-1 and ADAMTS-1 drive the balance toward a proangiogenic direction. This demonstrates that CCL2 has an angiogenic effect by interacting with macrophages. The expression of VEGF-A was reduced while expression of THBS-1 and ADAMTS-1 was increased in macrophages when the cells stimulated with rh-CX3CL1. This suggests that macrophages interacting with CX3CL1 secrete angiostatic cytokines and may have anti-angiogenic properties. The finding agrees with a previous study [36] . Zheng et al [37] also reported that the highly-expressed CX3CR1 subtype of macrophages has an inhibitory effect on pathological angiogenesis. To further investigate whether macrophages treated by CCL2 and CX3CL1 influence HREC function, we performed proliferation and migration assays. We showed that CCL2-stimulated macrophages promote proliferation and migration of HREC. In contrast, the potency of proliferation and migration was suppressed when co-cultured with CX3CL1-stimulated macrophages. This suggests that macrophages stimulated with various chemokines secrete a distinct profile of cytokines, giving rise to opposite effects on angiogenesis. These results are also consistent with reports that define macrophages as M1 and M2 subtypes [38] . Further investigation is needed to determine whether CCL2 and CX3CL1 induce macrophages to polarize into M1 or M2 subtypes. Our data suggest that CCL2 and CX3CL1 have opposite effects on angiogenesis.
In conclusion, we found both CCL2 and CX3CL1 alter the secretion profile of cytokines in macrophages toward proangiogenic or anti-angiogenic directions, and that these effects influence biological functions in HREC. These data may provide new insights into the mechanisms of recruited macrophages on angiogenesis, and may provide potential therapeutic targets for ocular neovascularization.
